Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724131 | SCV000228812 | uncertain significance | not provided | 2018-09-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001089098 | SCV000639505 | benign | Holoprosencephaly 3 | 2024-08-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000177008 | SCV000730594 | likely benign | not specified | 2017-12-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Athena Diagnostics | RCV000724131 | SCV001145617 | benign | not provided | 2019-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003338447 | SCV004060063 | likely benign | Inborn genetic diseases | 2023-06-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |